EM Advances: Effect of an emergency department sepsis protocol on time to antibiotics in severe sepsis

Canadian Journal of Emergency Medicine

Volumn 12, Issue 4, 2010, Pages 303-310

  Francis, Marc ^a   Rich, Tom ^a   Williamson, Tyler ^b   Peterson, Daniel ^c  

^a CALGARY HEALTH REGION   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Emergency department; Emergency medicine; Quality improvement; Sepsis; Septic shock; Severe sepsis

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFAZOLIN; CEFTRIAXONE; CLINDAMYCIN; CLOXACILLIN; DEXAMETHASONE; GENTAMICIN; LEVOFLOXACIN; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN; ANTIINFECTIVE AGENT;

ABDOMINAL INFECTION; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BONE AND JOINT INFECTIONS; CATHETER INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; CLINICAL PROTOCOL; COMMUNITY ACQUIRED PNEUMONIA; DISEASE SEVERITY; EMERGENCY WARD; ENDOCARDITIS; FASCIITIS; FEMALE; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEUTROPENIA; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RESUSCITATION; RETROSPECTIVE STUDY; SEPSIS; SKIN INFECTION; UROSEPSIS; CANADA; COMPARATIVE STUDY; EMERGENCY HEALTH SERVICE; EMPIRICAL RESEARCH; MIDDLE AGED; MORTALITY; PRACTICE GUIDELINE; STANDARD; TIME; TOTAL QUALITY MANAGEMENT;

AGED; ANTI-BACTERIAL AGENTS; CANADA; CLINICAL PROTOCOLS; EMERGENCY SERVICE, HOSPITAL; EMPIRICAL RESEARCH; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; QUALITY IMPROVEMENT; RETROSPECTIVE STUDIES; SEPSIS; TIME FACTORS;

EID: 79955057588     PISSN: 14818035     EISSN: 14818035     Source Type: Journal    
DOI: 10.1017/s1481803500012380     Document Type: Article

References (19)

1. Rivers EP, McIntyre L, Morro DC, et al. Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity. CMAJ 2005;173:1054-65. (Pubitemid 41546695)
2. McIntyre LA FD, Herbert PC, Cook DJ, et al. Are delays in the recognition and initial management of patients with severe sepsis associated with hospital mortality? Crit Care Med 2003;31[12(suppl)]:A75.
3. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-10. (Pubitemid 32641789)
4. Lundberg JS, Perl TM, Wiblin T, et al. Septic shock: an analysis of outcomes for patients with onset on hospital wards versus intensive care units. Crit Care Med 1998;26:1020-4. (Pubitemid 28272851)
5. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-73. (Pubitemid 38344143)
6. Dellinger RP, Carlet JM, Masur H, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Intensive Care Med 2004;30:536-55. (Pubitemid 38541501)
7. McCabe WR, Jackson GG. Gram negative bacteremia. Arch Intern Med 1962;110:847-55.
8. Leibovici L, Shraga I, Drucker M, et al. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med 1998;244:379-86. (Pubitemid 28513125)
9. Ibrahim EH, Sherman G, Ward S, et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcome in the ICU setting. Chest 2000;118:146-55. (Pubitemid 30485502)
10. Bochud PY, Bonten M, Marchetti O, et al. Antimicrobial therapy for patients with severe sepsis and septic shock: an evidence-based review. Crit Care Med 2004;32(suppl):S495-512.
11. Dellinger RP, Levy MM, Carlet JM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008;36:296-327.
12. Green RS, Djogovic D, Gray S, et al. Canadian Association of Emergency Physicians Sepsis Guidelines: the optimal management of severe sepsis in Canadian emergency departments. CJEM 2008;10:443-59.
13. Bone RC, Balk R, Cerra FB, et al. ACCP/SCCM consensus conference: definitions for sepsis and organ failure and guidelines for use of innovative therapies in sepsis. Chest 1992;101:1644-55.
14. Bonett DG, Price RM. Statistical inference for a linear function of medians: confidence intervals, hypothesis testing and sample size requirements. Psychol Methods 2002;7:370-83.
15. Rivers E, Nguyen B, Havstad S, et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-77.
16. Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia. Arch Intern Med 2004;164:637-44. (Pubitemid 38392978)
17. Meehan TP, Fine JM, Krumholz HM, et al. Quality of care, process and outcomes in elderly patients with pneumonia. JAMA 1997;278:2080-4. (Pubitemid 28016230)
18. Kumar A, Roberts D, Wood KE, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 2006;34:1589-96. (Pubitemid 43810035)
19. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, et al. Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 2003;31:2742-51. (Pubitemid 38010630)